Structural constraints of functional connectivity drive cognitive impairment in the early stages of multiple sclerosis.


Journal

Multiple sclerosis (Houndmills, Basingstoke, England)
ISSN: 1477-0970
Titre abrégé: Mult Scler
Pays: England
ID NLM: 9509185

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 8 12 2020
medline: 25 9 2021
entrez: 7 12 2020
Statut: ppublish

Résumé

The relationship between structural and functional deficits in multiple sclerosis (MS) is unclear. This study explored structure-function relationships during the 5 years following a clinically isolated syndrome and their role in cognitive performance. Thirty-two patients were enrolled after their first neurological episode suggestive of MS and followed for 5 years, along with 10 matched healthy controls. We assessed structural (using diffusion tensor imaging) and functional (using resting-state functional magnetic resonance imaging (fMRI)) brain network metrics, clinical and cognitive scores at each follow-up visit. Structural-functional coupling, calculated as the correlation coefficient between strengths of structural and functional networks, was used to assess structure-function relationships. Structural clustering coefficient was significantly increased after 5 years, whereas characteristic path length decreased. Structural connections decreased after 1 year and increased after 5 years. Functional connections and related path lengths were decreased after 5 years. Structural-functional coupling had increased significantly after 5 years. This structural-functional coupling was associated with cognitive and clinical evolution, with stronger coupling associated with a decline in both domains. Our findings provide novel biological evidence that MS leads to a more constrained anatomical-dependant functional connectivity. The collapse of this network seems to lead to both cognitive worsening and clinical disability.

Sections du résumé

BACKGROUND
The relationship between structural and functional deficits in multiple sclerosis (MS) is unclear.
OBJECTIVE
This study explored structure-function relationships during the 5 years following a clinically isolated syndrome and their role in cognitive performance.
METHODS
Thirty-two patients were enrolled after their first neurological episode suggestive of MS and followed for 5 years, along with 10 matched healthy controls. We assessed structural (using diffusion tensor imaging) and functional (using resting-state functional magnetic resonance imaging (fMRI)) brain network metrics, clinical and cognitive scores at each follow-up visit. Structural-functional coupling, calculated as the correlation coefficient between strengths of structural and functional networks, was used to assess structure-function relationships.
RESULTS
Structural clustering coefficient was significantly increased after 5 years, whereas characteristic path length decreased. Structural connections decreased after 1 year and increased after 5 years. Functional connections and related path lengths were decreased after 5 years. Structural-functional coupling had increased significantly after 5 years. This structural-functional coupling was associated with cognitive and clinical evolution, with stronger coupling associated with a decline in both domains.
CONCLUSION
Our findings provide novel biological evidence that MS leads to a more constrained anatomical-dependant functional connectivity. The collapse of this network seems to lead to both cognitive worsening and clinical disability.

Identifiants

pubmed: 33283582
doi: 10.1177/1352458520971807
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

559-567

Commentaires et corrections

Type : CommentIn

Auteurs

Ismail Koubiyr (I)

University of Bordeaux, Bordeaux, France; Inserm U1215 - Neurocentre Magendie, Bordeaux, France.

Mathilde Deloire (M)

CHU Pellegrin Bordeaux, Bordeaux, France.

Bruno Brochet (B)

University of Bordeaux, Bordeaux, France; Inserm U1215 - Neurocentre Magendie, Bordeaux, France; CHU Pellegrin Bordeaux, Bordeaux, France.

Pierre Besson (P)

Department of Radiology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA; Department of Neurological Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

Julie Charré-Morin (J)

CHU Pellegrin Bordeaux, Bordeaux, France.

Aurore Saubusse (A)

CHU Pellegrin Bordeaux, Bordeaux, France.

Thomas Tourdias (T)

University of Bordeaux, Bordeaux, France; Inserm U1215 - Neurocentre Magendie, Bordeaux, France; CHU Pellegrin Bordeaux, Bordeaux, France.

Aurélie Ruet (A)

University of Bordeaux, Bordeaux, France; Inserm U1215 - Neurocentre Magendie, Bordeaux, France; CHU Pellegrin Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH